Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05465187
Other study ID # PO22080
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2022
Est. completion date November 2022

Study information

Verified date July 2022
Source CHU de Reims
Contact Vincent LEGROS
Phone 03 26 78 30 21
Email vlegros@chu-reims.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Intensive care has known an important scientists progress for the last twenty years, allowing to heal more and more severe patients. Throughout the time, population has been getting old more and more, making patients affected by several diseases. As any medical specialty, intensive care has been confronted to these both evolutions. Thus ethical issues subsist for many years concerning rationality of cares intensity given to the patients. Withholding or withdrawing of life-sustaining therapy represents a non-negligible part of deaths in intensive care units in France. Throughout the years, it has been more and more leading French laws, as the Clayes-Leonetti law, one of the most important and recent one, which has governed ending life patients' rights since 2016. Thus it appears interesting to propose this study to evaluate proportion of withholding or withdrawing of life-sustaining therapy and their conditions of setting up in a maximum of intensive care units in the Grand-Est region in France in 2022 ; and to collect family's feelings concerning these decisions.


Description:

Intensive care has known an important scientists progress for the last twenty years, allowing healing more and more severe patients. Throughout the time, population has been getting old more and more, making patients affected by several comorbidities. As any medical specialty, intensive care has been confronted to these both evolutions. Thus ethical issues subsist for many years concerning rationality of cares intensity given to the patients. Depending on their age, and their comorbidities. Indeed, if cares are still possibles, disponibles and dispensables, they are not necessarily faithful. Withholding or withdrawing of life-sustaining therapy represents a non-negligible part of deaths in intensive care units in France. In the literature, these decisions concern 8,5% to 14% of patients residents in an intensive care unit in France, with variations depending on age, so can reach 20% on patients aged more than 80 years old. Among recent studies concerning withholding or withdrawing of life-sustaining therapy in French intensive care units, LATAREA is one of the first biggest (148 intensive care units, 7488 patients). It gives us important information about the subject. However, this study is an old one (1997), previous to Clayes-Leonetti law promulgation, which has governed ending life patients' rights since 2016. In LATAREA study, 11% of patients had measures of withholding or withdrawing of life-sustaining therapy; and mortality in intensive care units among these patients was at 78%. WLST conditions were described briefly. A study from EPILAT group, even if more recent (2015), gives us interesting data too, but it is an ancillary study with recruitment on only 616 intensive care beds, which represented 10% of intensive care beds at the time approximately. In this study, 14% of the patients were undergoing withholding or withdrawing of life-sustaining therapy. Among notable data, we can read that an external opinion was given in less than 50% of the cases, and that less than 2% of the patients had named somebody as one's support person or had written advanced directives. It also showed that WLST percentage crossed from 8% to 30% of admissions depending on intensive care units participating. By the way, it appears interesting to propose this study to know incidence and conditions of setting up withholding or withdrawing of life-sustaining therapy in a maximum of intensive care units in the Grand-Est region in France in 2022 ; and to collect family's feelings concerning these decisions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 250
Est. completion date November 2022
Est. primary completion date October 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria : - Adults patients hospitalized in an intensive care unit in Grand-Est region in France - For whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study - Contentment of the patient or their support person collected. Exclusion criteria : - Patients aged less than 18 years old - Who already have a decision of withholding or withdrawing of life-sustaining therapy taken before the beginning of the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Non applicable
Non applicable

Locations

Country Name City State
France Damien JOLLY Reims

Sponsors (1)

Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of withholding or withdrawing of life-sustaining therapy The primary outcome measure will consist in determine the part of withholding or withdrawing of life-sustaining therapy measures in Grand Est French ICU to learn about their importance. Thus we can compare it to data we know from previous studies first. Second, we can evaluate the evolution throughout the time if there is one and the impact of new laws for example. Day 28
Secondary Conditions of setting up withholding or withdrawing of life-sustaining therapy Conditions can be studied by screening many data, including : data related to the intensive care unit ; data related to generalities about withholding or withdrawing of life-sustaining therapy in the center ; data related to description of population studied ; data related to the period of study ; data concerning the characteristics of the patient and measure of withholding/withdrawing of life-sustaining therapy. All data will be collected via two CRF we elaborated. during the month of study
Secondary Agreement of these decisions with currently French legislation (" Claeys-Leonetti " lay, 2016) This secondary outcome measures rest on checking if the application of the measure studied in the intensive care unit is in accordance with the official law. Abuse could occur and had to be known to avoid misunderstandings and downward spiral. at the inclusion of the patients in the study
Secondary Questionnaire Family Satisfaction with ICU - 24Revisited This a validated questionary to evaluate family's patient satisfaction concerning the hospitalization of their relative in the intensive care unit. More precisely, this is a global evaluation in terms of quality of cares dispensed. It is divided in two parts, included satisfaction regarding cares and satisfaction with the decision concerning patient cares in severe illness status. It ends with some demographic informations. Finally it aims is to improve fonctionnement of intensive care units. during the month of study
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04476355 - Implementation of Physical Restraints Clinical Practice Guidelines for Critically Ill Patients Using the CAN-IMPLEMENT Framework N/A
Completed NCT05038514 - The Effect of Music Therapy in COVID-19 Patients Given Prone Position N/A
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT02819154 - Study of the Social and Psychological Consequences of ICU Hospitalization N/A
Completed NCT02995811 - Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness
Completed NCT03335527 - Impacts of Low-Dose Dexmedetomidine on Sleep Quality in Mechanically Ventilated ICU Patients Phase 4
Completed NCT03401411 - ICU Triage Practices in a Cancer Hospital N/A
Recruiting NCT06046690 - Comparison Of The Effects Of Inspiratory Muscle Training Methods in Mechanically Ventilated Patients N/A
Not yet recruiting NCT05960994 - Evaluation of the Clinical Impact of Different Telemedicine Practices in Intensive Care Units N/A
Completed NCT04372056 - The COVID-ICU Healthcare Professional Study
Completed NCT03545776 - Critical Care EEG Course
Completed NCT03180203 - Postoperative INTELLiVENT-ASV Ventilation N/A
Terminated NCT02101762 - Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters N/A
Completed NCT05874531 - End-expiratory Occlusion Test and Prediction of Preload Dependence
Not yet recruiting NCT04872881 - Comparison of Effectiveness of Different Airway Management Methods During Percutaneous Tracheostomy Phase 4
Completed NCT04664101 - REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19) N/A
Not yet recruiting NCT04507737 - Rapid Response Teams - How and Who? N/A
Completed NCT02040051 - Efficacy of Sound Insulation and Music Therapy on the Comfort of Mechanically Ventilated Patients Admitted to Intensive Care Unit N/A
Completed NCT01235637 - Alfentanil Versus Sufentanil for Pain in Children During for Tracheal Suction Phase 3
Recruiting NCT05660252 - Effect of Collaborative Requesting on DCD Refusal Rates: Randomized Controlled Trial N/A